头皮冷却预防化学疗法引起的持续性脱发:一项随机对照试验
Danbee Kang1,2, Juhee Cho1,2, Di Zhao3,4
1Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea.
概括
头皮冷却通过改善头发厚度,在六个月内显著减少化学疗法引起的持续性脱发症 (PCIA). 这种干预也减少了与脱发相关的患者痛苦.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 临床试验 临床试验
背景情况:
- 化疗诱导的脱发 (CIA) 是癌症治疗的常见副作用.
- 目前关于头皮冷却功效的研究受到短期随访的限制.
- 持续的化疗诱导性脱发症 (PCIA) 可以引起严重的痛苦.
研究的目的:
- 评估头皮冷却在减少化学疗法引起的持续性脱发症 (PCIA) 的有效性. 化学疗法后6个月.
- 评估头皮冷却对头发厚度,密度和患者报告的痛苦的影响.
主要方法:
- 在乳腺癌患者 (I-III阶段) 进行了一项开放的随机对照试验.
- 患者被分配到头皮冷却或常规护理 (2:1比).
- 主要结局是6个月的PCIA;次要结局包括头发指标和痛苦得分.
主要成果:
- 头皮冷却后PCIA的发病率为13.5%,对照组6个月后为52.0%.
- 头皮冷却显示了头发厚度变化 (9.0微米) 的有利差异.
- 在头皮冷却组观察到与化疗相关的痛苦减少 (CADS评分的平均差异为-3.2分).
结论:
- 头皮冷却有效地减少PCIA的发生率,主要是通过增强头发的厚度.
- 这种干预措施促进了质量的头发再生,并缓解了与CIA相关的痛苦.
- 需要进一步的研究来确定头皮冷却的长期益处.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
159
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
159
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
194
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
194
Decreased Body Temperature
607
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
607


